212 related articles for article (PubMed ID: 26204885)
1. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Lester J; Parry D; Pettit RJ; Byrne A
BMC Cancer; 2015 Jul; 15():544. PubMed ID: 26204885
[TBL] [Abstract][Full Text] [Related]
2. The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Farewell D; Lester JF; Parry D; Pettit R; Byrne A
Support Care Cancer; 2018 Jan; 26(1):119-127. PubMed ID: 28721555
[TBL] [Abstract][Full Text] [Related]
3. Performance status agreement assessed by the patient and clinician in a rapid access lung cancer service: Can either predict completion of treatment?
Collins JT; Noble S; Davies HE; Farewell D; Lester JF; Parry D; Byrne A
Eur J Cancer Care (Engl); 2019 May; 28(3):e13004. PubMed ID: 30761639
[TBL] [Abstract][Full Text] [Related]
4. [Cachexia and Sarcopenia Associated with Lung Cancer].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1537-1541. PubMed ID: 33268723
[TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
6. The assessment and impact of sarcopenia in lung cancer: a systematic literature review.
Collins J; Noble S; Chester J; Coles B; Byrne A
BMJ Open; 2014 Jan; 4(1):e003697. PubMed ID: 24384894
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
8. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
9. Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer.
Tobberup R; Rasmussen HH; Holst M; Jensen NA; Falkmer UG; Bøgsted M; Delekta AM; Carus A
Clin Nutr ESPEN; 2019 Dec; 34():94-100. PubMed ID: 31677719
[TBL] [Abstract][Full Text] [Related]
10. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract][Full Text] [Related]
11. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
12. Cancer cachexia in thoracic malignancy: a narrative review.
Kidd AC; Skrzypski M; Jamal-Hanjani M; Blyth KG
Curr Opin Support Palliat Care; 2019 Dec; 13(4):316-322. PubMed ID: 31592847
[TBL] [Abstract][Full Text] [Related]
13. Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract][Full Text] [Related]
14. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
[TBL] [Abstract][Full Text] [Related]
15. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.
Tsukioka T; Nishiyama N; Izumi N; Mizuguchi S; Komatsu H; Okada S; Toda M; Hara K; Ito R; Shibata T
Jpn J Clin Oncol; 2017 Apr; 47(4):363-368. PubMed ID: 28158497
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
Hung HY; Tseng YH; Chao HS; Chiu CH; Hsu WH; Hsu HS; Wu YC; Chou TY; Chen CK; Lan KL; Chen YW; Wu YH; Chen YM
PLoS One; 2020; 15(10):e0236503. PubMed ID: 33031375
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of a multimodal intervention on malnutrition in patients with lung cancer during primary anti-neoplastic treatment.
Tobberup R; Carus A; Rasmussen HH; Falkmer UG; Jorgensen MG; Schmidt EB; Jensen NA; Mark EB; Delekta AM; Antoniussen CS; Bøgsted M; Holst M
Clin Nutr; 2021 Feb; 40(2):525-533. PubMed ID: 32600857
[TBL] [Abstract][Full Text] [Related]
20. Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia.
Cortiula F; Hendriks LEL; van de Worp WRPH; Schols AMWJ; Vaes RDW; Langen RCJ; De Ruysscher D
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):55-67. PubMed ID: 35014216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
